SEC Form 4 · accession 0001352413-18-000004
MYRIAD GENETICS INC · MYGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Christopher Capone
Officer — President & C.E.O.
Period of report
Jul 11, 2018
Accepted (ET)
Jul 13, 2018 · 4:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000899923
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 11, 2018 | M | 77,654 | $30.12 | A | 409,829 | D | |
| Common Stock | Jul 11, 2018 | S | 77,654 | $41.00 | D | 332,175 | D | |
| Common Stock | Jul 11, 2018 | M | 2,346 | $30.12 | A | 334,521 | D | |
| Common Stock | Jul 11, 2018 | S | 2,346 | $41.00 | D | 332,175 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy) | $30.12 | Jul 11, 2018 | M | 2,346 | D | Feb 18, 2013 | Feb 18, 2019 | Common Stock | 2,346 | 0 | D |
| Non-Qualified Stock Option (right to buy) | $30.12 | Jul 11, 2018 | M | 77,654 | D | Feb 18, 2013 | Feb 18, 2019 | Common Stock | 77,654 | 0 | D |
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 trading plan.